ARTICLE | Distillery Therapeutics
Blocking a lipid hydrolase for liver fibrosis
October 2, 2020 11:12 PM UTC
DISEASE CATEGORY: Hepatic
INDICATION: Liver fibrosis; non-alcoholic steatohepatitis (NASH)...
BCIQ Company Profiles
BCIQ Target Profiles
DISEASE CATEGORY: Hepatic
INDICATION: Liver fibrosis; non-alcoholic steatohepatitis (NASH)...
BCIQ Company Profiles
BCIQ Target Profiles
BCIQ Company Profiles
BCIQ Target Profiles